Locally recurrent or metastatic breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

被引：40

作者：

Kataja, V. ^{[1
]}

Castiglione, M.

机构：

[1] Kuopio Univ Hosp, Dept Oncol, SF-70210 Kuopio, Finland

来源：

ANNALS OF ONCOLOGY | 2008年 / 19卷

关键词：

D O I：

10.1093/annonc/mdn072

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

[No abstract available]

引用

页码：11 / 13

页数：3

共 22 条

[1]

[Anonymous], BREAST CANC RES TREA

[2]

Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. [J].

Bartelink, H ;

Horiot, J ;

Poortmans, P ;

Struikmans, H ;

Van den Bogaert, W ;

Barillot, I ;

Fourquet, A ;

Borger, J ;

Jager, J ;

Hoogenraad, W ;

Collette, L ;

Pierart, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (19) :1378-1387

[3]

Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women:: Results of the tamoxifen or arimidex randomized group efficacy and tolerability study [J].

Bonneterre, J ;

Thürlimann, B ;

Robertson, JFR ;

Krzakowski, M ;

Mauriac, L ;

Koralewski, P ;

Vergote, I ;

Webster, A ;

Steinberg, M ;

von Euler, M .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) :3748-3757

[4]

Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer [J].

Burstein, HJ ;

Kuter, I ;

Campos, SM ;

Gelman, RS ;

Tribou, L ;

Parker, LM ;

Manola, J ;

Younger, J ;

Matulonis, U ;

Bunnell, CA ;

Partridge, AH ;

Richardson, PG ;

Clarke, K ;

Shulman, LN ;

Winer, EP .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) :2722-2730

[5]

IMPROVING THE QUALITY-OF-LIFE DURING CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - A COMPARISON OF INTERMITTENT AND CONTINUOUS TREATMENT STRATEGIES [J].

COATES, A ;

GEBSKI, V ;

BISHOP, JF ;

JEAL, PN ;

WOODS, RL ;

SNYDER, R ;

TATTERSALL, MHN ;

BYRNE, M ;

HARVEY, V ;

GILL, G ;

SIMPSON, J ;

DRUMMOND, R ;

BROWNE, J ;

VANCOOTEN, R ;

FORBES, JF .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (24) :1490-1495

[6]

Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment [J].

Falkson, G ;

Gelman, RS ;

Pandya, KJ ;

Osborne, CK ;

Tormey, D ;

Cummings, FJ ;

Sledge, GW ;

Abeloff, MD .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) :1669-1676

[7]

Cytotoxic and hormonal treatment for metastatic breast cancer: A systematic review of published randomized trials involving 31,510 women [J].

Fossati, R ;

Confalonieri, C ;

Torri, V ;

Ghislandi, E ;

Penna, A ;

Pistotti, V ;

Tinazzi, A ;

Liberati, A .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3439-3460

[8]

American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer [J].

Harris, Lyndsay ;

Fritsche, Herbert ;

Mennel, Robert ;

Norton, Larry ;

Ravdin, Peter ;

Taube, Sheila ;

Somerfield, Mark R. ;

Hayes, Daniel F. ;

Bast, Robert C., Jr. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) :5287-5312

[9]

Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment [J].

Howell, A ;

Robertson, JFR ;

Albano, JQ ;

Aschermannova, A ;

Mauriac, L ;

Kleeberg, UR ;

Vergote, I ;

Erikstein, B ;

Webster, A ;

Morris, C .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (16) :3396-3403

[10]

Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: A meta-analysis of four randomized trials [J].

Klijn, JGM ;

Blamey, RW ;

Boccardo, F ;

Tominaga, T ;

Duchateau, L ;

Sylvester, R .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) :343-353

← 1 2 3 →